Table 1:

Recipients’ demographic characteristics

DemographicsPMV (n = 17)Non-PMV (n = 34)P-Value
Age at surgery (years), mean ± SD (range)45.2 ± 9.6 (28–57)45.7 ± 13.2 (16–62)0.897
Sex (n)
 Female8130.546
 Male921
Body mass index (kg/m2), mean ± SD21.3 ± 4.621.5 ± 4.70.885
Smoking history (n)12220.674
Indications for CLT (n)
 Idiopathic interstitial pneumonias380.731
 Other interstitial pneumonias390.728
 Idiopathic pulmonary artery hypertension200.107
 Chronic obstructive pulmonary disease030.542
 Graft versus host disease310.102
 Others6131.000
Mean pulmonary artery pressure (mmHg), mean ± SD28.4 ± 15.023.9 ± 2.60.289
Pulmonary hypertension (>25 mmHg) (n)680.375
Cardiac index (l/min/m2), median [interquartile range]2.7 [2.5–3.4]2.8 [2.4–3.0]0.433
Lung function, mean ± SD
 FVC (l)1.8 ± 0.82.2 ± 1.00.146
 %FVC (%)54.0 ± 22.061.2 ± 25.50.322
 FEV1 (l)1.4 ± 0.61.4 ± 0.80.818
 FEV1/FVC (%)74.7 ± 24.264.2 ± 27.80.189
DemographicsPMV (n = 17)Non-PMV (n = 34)P-Value
Age at surgery (years), mean ± SD (range)45.2 ± 9.6 (28–57)45.7 ± 13.2 (16–62)0.897
Sex (n)
 Female8130.546
 Male921
Body mass index (kg/m2), mean ± SD21.3 ± 4.621.5 ± 4.70.885
Smoking history (n)12220.674
Indications for CLT (n)
 Idiopathic interstitial pneumonias380.731
 Other interstitial pneumonias390.728
 Idiopathic pulmonary artery hypertension200.107
 Chronic obstructive pulmonary disease030.542
 Graft versus host disease310.102
 Others6131.000
Mean pulmonary artery pressure (mmHg), mean ± SD28.4 ± 15.023.9 ± 2.60.289
Pulmonary hypertension (>25 mmHg) (n)680.375
Cardiac index (l/min/m2), median [interquartile range]2.7 [2.5–3.4]2.8 [2.4–3.0]0.433
Lung function, mean ± SD
 FVC (l)1.8 ± 0.82.2 ± 1.00.146
 %FVC (%)54.0 ± 22.061.2 ± 25.50.322
 FEV1 (l)1.4 ± 0.61.4 ± 0.80.818
 FEV1/FVC (%)74.7 ± 24.264.2 ± 27.80.189

CLT: cadaveric lung transplantation; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; PMV: prolonged mechanical ventilation; SD: standard deviation.

Table 1:

Recipients’ demographic characteristics

DemographicsPMV (n = 17)Non-PMV (n = 34)P-Value
Age at surgery (years), mean ± SD (range)45.2 ± 9.6 (28–57)45.7 ± 13.2 (16–62)0.897
Sex (n)
 Female8130.546
 Male921
Body mass index (kg/m2), mean ± SD21.3 ± 4.621.5 ± 4.70.885
Smoking history (n)12220.674
Indications for CLT (n)
 Idiopathic interstitial pneumonias380.731
 Other interstitial pneumonias390.728
 Idiopathic pulmonary artery hypertension200.107
 Chronic obstructive pulmonary disease030.542
 Graft versus host disease310.102
 Others6131.000
Mean pulmonary artery pressure (mmHg), mean ± SD28.4 ± 15.023.9 ± 2.60.289
Pulmonary hypertension (>25 mmHg) (n)680.375
Cardiac index (l/min/m2), median [interquartile range]2.7 [2.5–3.4]2.8 [2.4–3.0]0.433
Lung function, mean ± SD
 FVC (l)1.8 ± 0.82.2 ± 1.00.146
 %FVC (%)54.0 ± 22.061.2 ± 25.50.322
 FEV1 (l)1.4 ± 0.61.4 ± 0.80.818
 FEV1/FVC (%)74.7 ± 24.264.2 ± 27.80.189
DemographicsPMV (n = 17)Non-PMV (n = 34)P-Value
Age at surgery (years), mean ± SD (range)45.2 ± 9.6 (28–57)45.7 ± 13.2 (16–62)0.897
Sex (n)
 Female8130.546
 Male921
Body mass index (kg/m2), mean ± SD21.3 ± 4.621.5 ± 4.70.885
Smoking history (n)12220.674
Indications for CLT (n)
 Idiopathic interstitial pneumonias380.731
 Other interstitial pneumonias390.728
 Idiopathic pulmonary artery hypertension200.107
 Chronic obstructive pulmonary disease030.542
 Graft versus host disease310.102
 Others6131.000
Mean pulmonary artery pressure (mmHg), mean ± SD28.4 ± 15.023.9 ± 2.60.289
Pulmonary hypertension (>25 mmHg) (n)680.375
Cardiac index (l/min/m2), median [interquartile range]2.7 [2.5–3.4]2.8 [2.4–3.0]0.433
Lung function, mean ± SD
 FVC (l)1.8 ± 0.82.2 ± 1.00.146
 %FVC (%)54.0 ± 22.061.2 ± 25.50.322
 FEV1 (l)1.4 ± 0.61.4 ± 0.80.818
 FEV1/FVC (%)74.7 ± 24.264.2 ± 27.80.189

CLT: cadaveric lung transplantation; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; PMV: prolonged mechanical ventilation; SD: standard deviation.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close